Accelerating proteomics together
PEA on NGS
Together with the Olink community
“This new technology allows us to go down into the low abundant proteins in a very accurate and sensitive way to better understand human biology and disease. That is why I’m so excited about the future.”
Mathias Uhlén
Professor of Microbiology at Royal Institute of Technology, Stockholm.
“This technological leap enables us to more broadly add proteins alongside DNA and RNA when we conduct studies of human biology.”
Robert Gerszten
Herman Data Professor of Medicine at Harvard Medical School and also a Senior Associate Member of the Broad Institute
“I think that Olink will be an important addition to the tools we have for biomarker discovery in plasma, CSF, and other biofluids due to the speed and very small sample amounts required for analysis.”
Steven Carr
Senior Director of Proteomics, the Broad Institute
About Olink
Enable understanding of real-time human biology
Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.